People are battling ‘ghost fat’ after losing weight on GLP-1s
Many Americans are experiencing a phenomenon called 'ghost fat' after significant weight loss from GLP-1 drugs like Wegovy and Zepbound. This condition leads individuals to perceive themselves as larger than they actually are, creating a disconnect between their physical appearance and self-image. Experts suggest that cognitive behavioral therapy may help individuals align their self-perception with their new bodies.
- ▪One in eight US adults is using GLP-1 drugs to lose weight.
- ▪Users typically lose between 15% and 20% of their body weight within a year.
- ▪Nearly two-thirds of women studied post-bariatric surgery still perceived themselves as obese despite weight loss.
Opening excerpt (first ~120 words) tap to expand
Mental Health People are battling ‘ghost fat’ after losing weight on GLP-1s By McKenzie Beard Published June 6, 2026, 10:30 a.m. ET See more of our coverage in your search results. Add The New York Post on Google Sometimes, seeing isn’t believing. Across the country, Americans are losing weight faster than ever thanks to blockbuster obesity drugs like Wegovy and Zepbound, with roughly one in eight US adults now turning to GLP-1s to slim down. But for some users, the dramatic physical changes come with an unexpected psychological twist. 3 Users of GLP-1 drugs tend to shed between 15% and 20% of their body weight within one year.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
